Diagnostic, Prognostic, and Therapeutic Implications of Genetic Testing for Hypertrophic Cardiomyopathy
Top Cited Papers
- 7 July 2009
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 54 (3), 201-211
- https://doi.org/10.1016/j.jacc.2009.02.075
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin CJournal of Molecular and Cellular Cardiology, 2008
- Sex hormone receptor gene variation associated with phenotype in male hypertrophic cardiomyopathy patientsJournal of Molecular and Cellular Cardiology, 2008
- MicroRNA Regulation of Cell Lineages in Mouse and Human Embryonic Stem CellsCell Stem Cell, 2008
- Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophyJournal of Molecular and Cellular Cardiology, 2007
- Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathyHuman Molecular Genetics, 2007
- Myozenin 2 Is a Novel Gene for Human Hypertrophic CardiomyopathyCirculation Research, 2007
- A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failureProceedings of the National Academy of Sciences, 2006
- Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathyBiochemical and Biophysical Research Communications, 2006
- Structural Analysis of the Titin Gene in Hypertrophic Cardiomyopathy: Identification of a Novel Disease GeneBiochemical and Biophysical Research Communications, 1999
- Mapping a Gene for Familial Hypertrophic Cardiomyopathy to Chromosome 14q1New England Journal of Medicine, 1989